What’s new and crucial in genito-urinary (GU) cancer treatment? This is the question that has driven the European Multidisciplinary Congress on Urological Cancers (EMUC) for almost two decades now. Top experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology gather at the congress to offer insights on the best practices, developments on major trials, and breakthroughs. The upcoming 16th edition (EMUC24), which will take place in Lisbon, Portugal will be no different. Please be wary of third parties attempting to contact you. Disregard any emails from booking agencies requesting your travel information, credit card details, or attempting to sell accommodations or registrations. Do not click on any of the links or submit any information to these parties (i.e. Global Travel Experts, Ehotel services, Royal Visit). All official communication regarding bookings and registrations will come directly from Congress Consultants B.V. or K.I.T. Group GmbH. Prof. Karim Fizazi (ESMO) Dr. Alison Tree (ESTRO) Prof. Arnulf Stenzl (EAU) The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific... Individualised approaches to kidney cancer were deliberated in Plenary Session 12 on the afternoon of day three at EMUC23.... The second half of Plenary Session 13 “New standards and novel approaches in advanced prostate cancer” was spearheaded by...Dear friends and colleagues,
Steering committee
Steering committee
Steering committeeWhy you should attend this congress
News and reports
Cross-disciplines and AI in focus at EMUC24: An advance look at what awaits you at the congress
RCC: Molecular imaging techniques? Delayed nephrectomy?
mCRPC: Insights on Lu-PSMA, PARP inhibitors, and new targeted approaches
